C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase
Enzyme and cellular assay results for a number of new modifications on the C-8 aminobenzyl unit are reported. Pyrazole sulfonic acid amide analogs are shown to provide improved inhibitors of cPEPCK and a new π–π interaction with the protein. New modifications on the C-8 4-aminobenzyl unit of the pre...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters Vol. 17; no. 14; pp. 3835 - 3839 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford
Elsevier Ltd
15-07-2007
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Enzyme and cellular assay results for a number of new modifications on the
C-8 aminobenzyl unit are reported. Pyrazole sulfonic acid amide analogs are shown to provide improved inhibitors of cPEPCK and a new π–π interaction with the protein.
New modifications on the
C-8 4-aminobenzyl unit of the previously reported 3-alkyl-1,8-dibenzylxanthine inhibitors of cPEPCK are presented. The most active compound reported here is the 5-chloro-1,3-dimethyl-1
H-pyrazole-4-sulfonic acid amide derivative
2 with an IC
50 of 0.29
±
0.08
μM. An X-ray analysis of a heteroaromatic sulfonamide is presented showing a new π–π interaction. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 BNL-81179-2008-JA DE-AC02-98CH10886 Doe - Office Of Science |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2007.05.013 |